Ergoteles’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-589
Closed -$6.62K 1742
2022
Q4
$6.62K Buy
+589
New +$6.62K ﹤0.01% 1380
2022
Q3
Sell
-5,888
Closed -$74K 1976
2022
Q2
$74K Buy
+5,888
New +$74K ﹤0.01% 1540
2021
Q3
Sell
-1,364
Closed -$237K 1647
2021
Q2
$237K Buy
+1,364
New +$237K 0.01% 1196